Study Stopped
poor recruitment
Autologous Endometrial Coculture (AECCT)
AECCT
A Randomized Controlled Trial Evaluating Autologous Endometrial Coculture (AECC) As An Effective Tool For Young Patients With Poor Ovarian Reserve
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to determine if the use of Autologous Endometrial Coculture (AECC) in young in vitro fertilization (IVF) patients with poor ovarian reserve improves pregnancy outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 11, 2011
CompletedFirst Posted
Study publicly available on registry
November 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJune 12, 2015
June 1, 2015
4.7 years
November 11, 2011
June 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy outcome
1 month
Secondary Outcomes (1)
Embryo quality
1 month
Study Arms (2)
No AECC
PLACEBO COMPARATORRoutine procedures without AECC
AECC
EXPERIMENTALEndometrial biopsy and Autologous endometrial coculture
Interventions
endometrial biopsy with autologous endometrial coculture
routine procedures with out biopsy
Eligibility Criteria
You may qualify if:
- Healthy women undergoing IVF at CRMI
- Age ≤ 38 years
- Poor ovarian reserve with antral follicle count less than 6 follicles, cycle day 2/3 FSH \> 12 ng/ml, AMH \< 0.5 ng/ml
You may not qualify if:
- Healthy women undergoing IVF with male factor, severe endometriosis, or tubal factor infertility
- Donor patients
- Contraindications for the use of gonadotropins (i.e. pregnancy, lactation, undiagnosed vaginal bleeding or ovarian cysts)
- Recent or current medical conditions where the patient is not medically stable to undergo stimulation or egg retrieval, HIV infection, diabetes, cardiovascular disease, gastrointestinal, hepatic disease, renal or pulmonary disease.
- Any patient who is not a candidate for IVF
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Reproducutve Medicine; Weill Cornell Medical College
New York, New York, 10021, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Spandorfer Steven, MD
Weill Medical College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 11, 2011
First Posted
November 17, 2011
Study Start
October 1, 2009
Primary Completion
June 1, 2014
Study Completion
June 1, 2015
Last Updated
June 12, 2015
Record last verified: 2015-06